Roberto Aja
Investor Relations
Replay available
SkinHealth Systems Inc. (NASDAQ: SKIN) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Executive Officer
Chief Financial Officer
Equity Analyst, J.P. Morgan
Analyst, Stifel (for John Block)
Analyst, TV Securities
Analyst, The Benchmark Company
Analyst, Raymond James
Watch the replay and follow the connected company analysis, news, and investor updates for Skinhealth Systems Inc..
WEBVTT 00:00:00.000 -- 00:00:05.360 Good day and welcome to the Beauty Health Company Second Quarter 2025 earnings 00:00:05.360 -- 00:00:09.620 conference call. All participants will be in the listen only mode. 00:00:09.620 -- 00:00:13.780 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.780 -- 00:00:18.880 keys followed by zero. After today's presentation, there will be an opportunity to 00:00:18.880 -- 00:00:24.760 ask questions. To ask a question, you may press star then one on touch tone four. 00:00:24.760 -- 00:00:27.730 To withdraw your questions, please press star then two. 00:00:27.730 -- 00:00:30.660 Please note, this event is being recorded. 00:00:30.660 -- 00:00:36.060 I would now like to turn the conference over to Roberto Aja, Investor Relations. 00:00:36.060 -- 00:00:38.560 Please go ahead. 00:00:38.720 -- 00:00:44.060 Thank you, operator, and good afternoon. Thank you for joining the Beauty Health Company's 00:00:44.060 -- 00:00:49.060 2025 Second Quarter Conference call. Our earnings press release was 00:00:49.060 -- 00:00:55.160 issued this afternoon and is available on our investor relations site at beautyhealth.com. 00:00:55.240 -- 00:01:00.120 Joining me on the call today is Beauty Health's Chief Executive Officer, Marla Beck, 00:01:00.120 -- 00:01:03.600 along with her Chief Financial Officer, Michael Monahan. 00:01:03.600 -- 00:01:08.860 Before we begin, please note that today's discussion includes forward looking statements, 00:01:08.860 -- 00:01:14.580 including guidance and underlying assumptions, which are subject to risks and uncertainties. 00:01:14.580 -- 00:01:17.560 Actual results may differ materially. 00:01:17.560 -- 00:01:23.740 For a further discussion of risks related to our business, p...